We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Computerized Drug Warning Alerts Remain Largely Ignored

By HospiMedica International staff writers
Posted on 19 Apr 2012
A new study finds that 96% of computerized drug warning alerts generated in hospitals are overridden out of hand. More...


Researchers at the Johns Hopkins Bayview Medical Center (Baltimore, MD, USA) examined data from the 410-bed academic medical center to clarify the factors associated with accepting or overriding a warning from the hospital computerized provider order entry (CPOE) system, developed to generate warnings when there is the possibility of allergy, adverse events, interactions, and duplications, with the intent of increasing inpatient safety. To do so, they identified 6,646 patients - mean age 57, 44% male, with a mean length of hospital stay of four days. When differentiated, 45% were on medical wards, 29% in psychiatric departments, 28% on surgical wards, , and small numbers in other departments such as obstetrics and gynecology.

The researchers found that for the patients whose medication orders generated at least a single warning, the median range of medications per patient was four. The reasons for the warnings were duplications in 47%, potential interactions in 47%, allergies in 6%, and only 0.1% for potential adverse reactions. One-quarter of the warnings were for parenteral medications, and 13% were on the list of high-alert medications. While only 4% of the warnings for oral medications were accepted, warnings for parenteral medications were accepted twice as often, at 8%. The study was presented at the Society of Hospital Medicine (SHM) annual meeting, held during April 2012 in San Diego (CA, USA).

“The least common warnings were those that were most frequently accepted, with the average accepted warnings for drug interactions and allergy being 37% and 10%, respectively,” said lead author and study presenter Amy Knight, MD. “The problem with these computerized warning systems is that providers develop 'alert fatigue' and end up overriding many potentially important warnings.”

“Developers of these computerized provider systems need to revise their programs to more clearly differentiate between types of warnings and, in particular, to distinguish the warnings that are most likely to have severe consequences,” concluded Dr. Knight.

Related Links:

Johns Hopkins Bayview Medical Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Anesthetic Gas Measurement Module
Scio Four
New
Dual Chamber Warming Cabinet
D-Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.